Evidence map›Paper›PMID 29891918›Full record

ArticleNature communications2018

Structural basis for the regulation of human 5,10-methylenetetrahydrofolate reductase by phosphorylation and S-adenosylmethionine inhibition.

D Sean Froese, Jolanta Kopec, Elzbieta Rembeza, Gustavo Arruda Bezerra, Anselm Erich Oberholzer, Terttu Suormala, Seraina Lutz, Rod Chalk, Oktawia Borkowska, Matthias R Baumgartner and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 86 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  4. Targeting Mutant Phenylalanine Hydroxylase With Pyrimidine-Triazole Conjugates: A Primary Framework for Candidate Chaperone-Based Strategies in Phenylketonuria.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. International journal of molecular medicine · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Mechanisms and rationales of SAM homeostasis.Trends in biochemical sciences · 2025
    Review
  15. Article
  16. Article
  17. The T120P or M172V mutation onEmerging microbes & infections · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

D Sean FroeseDivision of Metabolism and Children's Research Center, University Children's Hospital, CH-8032, Zürich, Switzerland. sean.froese@kispi.uzh.ch.ORCID http://orcid.org/0000-0003-1557-3517
Jolanta KopecStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Elzbieta RembezaStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Gustavo Arruda BezerraStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Anselm Erich OberholzerStructural Biology Community Laenggasse (sbcl), CH-3000, Bern, Switzerland.
Terttu SuormalaDivision of Metabolism and Children's Research Center, University Children's Hospital, CH-8032, Zürich, Switzerland.
Seraina LutzDivision of Metabolism and Children's Research Center, University Children's Hospital, CH-8032, Zürich, Switzerland.
Rod ChalkStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Oktawia BorkowskaStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK.
Matthias R BaumgartnerDivision of Metabolism and Children's Research Center, University Children's Hospital, CH-8032, Zürich, Switzerland.ORCID http://orcid.org/0000-0002-9270-0826
Wyatt W YueStructural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX3 7DQ, UK. wyatt.yue@sgc.ox.ac.uk.ORCID http://orcid.org/0000-0001-6959-6007
University of Oxford · GBUniversity Children's Hospital Zurich · CH

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation) SNSF 31003A_156907Wellcome TrustWellcome Trust 106169/ZZ14/Z
6 · The paper itself

Abstract

The folate and methionine cycles are crucial for biosynthesis of lipids, nucleotides and proteins, and production of the methyl donor S-adenosylmethionine (SAM). 5,10-methylenetetrahydrofolate reductase (MTHFR) represents a key regulatory connection between these cycles, generating 5-methyltetrahydrofolate for initiation of the methionine cycle, and undergoing allosteric inhibition by its end product SAM. Our 2.5 Å resolution crystal structure of human MTHFR reveals a unique architecture, appending the well-conserved catalytic TIM-barrel to a eukaryote-only SAM-binding domain. The latter domain of novel fold provides the predominant interface for MTHFR homo-dimerization, positioning the N-terminal serine-rich phosphorylation region near the C-terminal SAM-binding domain. This explains how MTHFR phosphorylation, identified on 11 N-terminal residues (16 in total), increases sensitivity to SAM binding and inhibition. Finally, we demonstrate that the 25-amino-acid inter-domain linker enables conformational plasticity and propose it to be a key mediator of SAM regulation. Together, these results provide insight into the molecular regulation of MTHFR.

Indexed as

Amino Acid SequenceCatalytic DomainCrystallography, X-RayEvolution, MolecularHumansKineticsMass SpectrometryMethylenetetrahydrofolate Reductase (NADPH2)Models, MolecularMolecular Dynamics SimulationNADPPhosphorylationProtein DomainsProtein FoldingProtein Structure, QuaternaryRecombinant ProteinsMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, humanNADPRecombinant ProteinsS-Adenosylmethionine

Identifiers

PMID29891918
PMCPMC5995969
OpenAlexW2806513592

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.